NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 175 filers reported holding NEVRO CORP in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $812,372 | -16.5% | 42,267 | +10.4% | 0.01% | -16.7% |
Q2 2023 | $972,849 | -36.7% | 38,271 | -10.0% | 0.01% | -33.3% |
Q1 2023 | $1,536,411 | -5.2% | 42,501 | +3.8% | 0.01% | 0.0% |
Q4 2022 | $1,621,026 | -36.7% | 40,935 | -25.5% | 0.01% | -30.8% |
Q3 2022 | $2,559,000 | +6.5% | 54,915 | +0.2% | 0.01% | +30.0% |
Q2 2022 | $2,402,000 | -31.9% | 54,810 | +12.5% | 0.01% | -28.6% |
Q1 2022 | $3,525,000 | +17.2% | 48,735 | +31.4% | 0.01% | -17.6% |
Q4 2021 | $3,007,000 | -20.1% | 37,092 | +14.7% | 0.02% | -19.0% |
Q3 2021 | $3,763,000 | -34.7% | 32,334 | -7.0% | 0.02% | -43.2% |
Q2 2021 | $5,765,000 | – | 34,773 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |